ClinConnect ClinConnect Logo
Search / Trial NCT06027242

Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 5, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Gastric Cancer Gastrectomy Sarcopenia

ClinConnect Summary

This clinical trial is exploring the effects of a supplement called glutamine on patients with gastric cancer who have had surgery to remove part or all of their stomach (a procedure known as gastrectomy). The main goal is to see if glutamine can help reduce muscle loss, a condition known as sarcopenia, which can occur after such surgery. The study will also look at how glutamine affects patients' physical activity, weight changes, and overall nutrition.

To participate, you need to be an adult who has been diagnosed with gastric cancer and is scheduled for gastrectomy. However, if you have severe liver or kidney problems, cannot eat normally after surgery, or are unable to wear a device that tracks your activity, you would not qualify for this trial. If you join, you can expect to receive glutamine supplements and be monitored for changes in your health and nutrition over time. This study is currently recruiting participants, and it's a chance to contribute to important research that may help improve recovery for future gastric cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult gastric cancer receiving gastrectomy
  • Exclusion Criteria:
  • Hepatic insufficiency
  • Renal insufficiency
  • can not tolerate oral or enteral feeding 7 days after gastrectomy
  • can not receive computed tomograph
  • can not waer the wearable devices

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Trial Officials

Jin-Ming Wu, MD

Principal Investigator

National Taiwan University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported